ES3014539T3 - New formulations of amisulpride - Google Patents
New formulations of amisulpride Download PDFInfo
- Publication number
- ES3014539T3 ES3014539T3 ES20764447T ES20764447T ES3014539T3 ES 3014539 T3 ES3014539 T3 ES 3014539T3 ES 20764447 T ES20764447 T ES 20764447T ES 20764447 T ES20764447 T ES 20764447T ES 3014539 T3 ES3014539 T3 ES 3014539T3
- Authority
- ES
- Spain
- Prior art keywords
- day
- amisulpride
- dose
- weeks
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102019000013524A IT201900013524A1 (it) | 2019-07-31 | 2019-07-31 | Nuove formulazioni di amisulpride |
| PCT/IB2020/057182 WO2021019479A2 (en) | 2019-07-31 | 2020-07-30 | New formulations of amisulpride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES3014539T3 true ES3014539T3 (en) | 2025-04-23 |
Family
ID=69105952
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES20764447T Active ES3014539T3 (en) | 2019-07-31 | 2020-07-30 | New formulations of amisulpride |
| ES24206976T Active ES3057288T3 (en) | 2019-07-31 | 2020-07-30 | New formulations of amisulpride |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES24206976T Active ES3057288T3 (en) | 2019-07-31 | 2020-07-30 | New formulations of amisulpride |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP4003297B1 (pl) |
| BR (1) | BR112021025616A2 (pl) |
| ES (2) | ES3014539T3 (pl) |
| HU (1) | HUE070449T2 (pl) |
| IT (1) | IT201900013524A1 (pl) |
| LT (2) | LT4003297T (pl) |
| PL (2) | PL4527373T3 (pl) |
| PT (2) | PT4003297T (pl) |
| WO (1) | WO2021019479A2 (pl) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201702250D0 (en) * | 2017-02-10 | 2017-03-29 | Acacia Pharma Ltd | Method |
-
2019
- 2019-07-31 IT IT102019000013524A patent/IT201900013524A1/it unknown
-
2020
- 2020-07-30 ES ES20764447T patent/ES3014539T3/es active Active
- 2020-07-30 EP EP20764447.7A patent/EP4003297B1/en active Active
- 2020-07-30 PT PT207644477T patent/PT4003297T/pt unknown
- 2020-07-30 LT LTEPPCT/IB2020/057182T patent/LT4003297T/lt unknown
- 2020-07-30 LT LTEP24206976.3T patent/LT4527373T/lt unknown
- 2020-07-30 ES ES24206976T patent/ES3057288T3/es active Active
- 2020-07-30 WO PCT/IB2020/057182 patent/WO2021019479A2/en not_active Ceased
- 2020-07-30 BR BR112021025616A patent/BR112021025616A2/pt unknown
- 2020-07-30 PL PL24206976.3T patent/PL4527373T3/pl unknown
- 2020-07-30 HU HUE20764447A patent/HUE070449T2/hu unknown
- 2020-07-30 PT PT242069763T patent/PT4527373T/pt unknown
- 2020-07-30 EP EP24206976.3A patent/EP4527373B1/en active Active
- 2020-07-30 PL PL20764447.7T patent/PL4003297T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021019479A3 (en) | 2021-03-11 |
| ES3057288T3 (en) | 2026-02-27 |
| LT4003297T (lt) | 2025-03-10 |
| PL4527373T3 (pl) | 2025-12-01 |
| PL4003297T3 (pl) | 2025-04-07 |
| LT4527373T (lt) | 2026-01-12 |
| HUE070449T2 (hu) | 2025-06-28 |
| PT4527373T (pt) | 2025-12-23 |
| EP4527373B1 (en) | 2025-09-24 |
| WO2021019479A2 (en) | 2021-02-04 |
| BR112021025616A2 (pt) | 2022-02-08 |
| EP4003297B1 (en) | 2024-11-20 |
| EP4527373A1 (en) | 2025-03-26 |
| PT4003297T (pt) | 2025-02-21 |
| IT201900013524A1 (it) | 2021-01-31 |
| EP4003297A2 (en) | 2022-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2685178T3 (es) | Soluciones pediátricas que contienen un beta bloqueante | |
| ES2617252T3 (es) | Solución oral que comprende clorhidrato de atomoxetina | |
| ES2398267T3 (es) | Composiciones intranasales | |
| ES2822562T3 (es) | Composiciones intranasales para el tratamiento de enfermedades y trastornos neurológicos y degenerativos | |
| ES2707775T3 (es) | Composición que contiene hesperidina | |
| Kulkarni et al. | Oral jelly of metformin hydrochloride–Formulation development using Design of Experiments and characterization | |
| ES3057288T3 (en) | New formulations of amisulpride | |
| RU2582954C2 (ru) | Фармацевтическая композиция в форме пероральной суспензии, которая содержит фракцию флавоноида и ксантановую камедь | |
| CA3032750C (en) | Medication with improved taste and sensory experience | |
| AU2017207806B2 (en) | Betamethasone oral spray formulation and method of use to treat ataxia | |
| ES2943933T3 (es) | Colirios de palonosetrón para el tratamiento o la prevención de náuseas y vómitos | |
| JP7081002B2 (ja) | 液状口腔咽喉薬 | |
| ES2565653T3 (es) | Uso de betanecol para tratamiento de xerostomía | |
| TW201442738A (zh) | 腫瘤學藥物之口服調配物及懸浮液 | |
| ES2215025T3 (es) | Formulacion farmaceutica efervescente, que contiene metamizol. | |
| ES2887625T3 (es) | Soluciones orales que comprenden tramadol | |
| JP2018039775A (ja) | ロキソプロフェン含有医薬製剤 | |
| Alfred-Ugbenbo et al. | Prescription analysis for extemporaneous preparations in hospital pharmacies of Southern Nigeria | |
| GR1009815B (el) | Μη αλκοολουχο ελευθερο απο συντηρητικα και καταλληλο για απο του στοματος χορηγηση πολυδοσικο διαλυμα λεβοθυροξινης για την αντιμετωπιση του υποθυρεοειδισμου | |
| ES3031740T3 (en) | Palatable liquid solution containing high concentration of miglustat | |
| KR20140145508A (ko) | 암브록솔 및 레보드로프로피진을 포함하는 안정성이 개선된 경구용 액상 제제 | |
| JP4195218B2 (ja) | 弱アルカリで安定化される薬剤を含む医薬用液剤 | |
| JP7277899B2 (ja) | 液体組成物と、その液体組成物の発泡を抑制する方法及び発泡抑制剤 | |
| JP6616968B2 (ja) | 医薬組成物 | |
| JP2018108963A (ja) | 液状口腔咽喉薬 |